Pfizer PFE and BioNTech BNTX announced that they are planning to test a three-dose regimen of their COVID-19 vaccine, Comirnaty (BNT162b), in children aged six months to five years, following routine ...
(AP) – A real-world test of Pfizer’s COVID-19 vaccine in more than half a million people confirms that it’s very effective at preventing serious illness or death, even after one dose. Wednesday’s ...
Pfizer and BioNTech are testing a third dose of their Covid-19 vaccine in an ongoing trial of children ages 6 months to under 5 years after the companies found that the two-dose regimen didn’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results